Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, July 07, 2014 11:08:23 AM
bullish
$NVAX
DD Notes ~ http://www.ddnotesmaker.com/NVAX
##### recent news/filings ~ source: finance.yahoo.com
Mon, 23 Jun 2014 20:11:05 GMT ~ Novavax Recognized as One of The Washington Post's Top Workplaces
[GlobeNewswire] - GAITHERSBURG, Md. -- Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, is pleased ...
read full: http://finance.yahoo.com/news/novavax-recognized-one-washington-posts-201105900.html
*********************************************************
Thu, 19 Jun 2014 20:10:00 GMT ~ Novavax Announces Management Promotions
[GlobeNewswire] - GAITHERSBURG, Md. -- Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants, announced ...
read full: http://finance.yahoo.com/news/novavax-announces-management-promotions-201000577.html
*********************************************************
Wed, 18 Jun 2014 22:46:26 GMT ~ Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus
[at noodls] - Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus Gaithersburg, MD (June 18, 2014)-Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company focused on the discovery, ...
read full: http://www.noodls.com/view/DFB0043EDBBF36B69C2A9B26E32E3A6F4BC7BA02
*********************************************************
Wed, 18 Jun 2014 20:40:30 GMT ~ Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus
[GlobeNewswire] - GAITHERSBURG, Md. -- Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced ...
read full: http://finance.yahoo.com/news/long-time-novavax-board-member-204030498.html
*********************************************************
Wed, 18 Jun 2014 20:31:38 GMT ~ NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securit
read full: http://biz.yahoo.com/e/140618/nvax8-k.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVAX/company-info
Ticker: $NVAX
OTC Market Place: Not Available
CIK code: 0001000694
Company name: Novavax, Inc.
Company website: http://www.novavax.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001000694&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/NVAX/filings
Latest financials: http://www.otcmarkets.com/stock/NVAX/financials
Latest news: http://www.otcmarkets.com/stock/NVAX/news - http://finance.yahoo.com/q/h?s=NVAX+Headlines
Major holdings: http://data.cnbc.com/quotes/NVAX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=NVAX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/NVAX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=NVAX
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=NVAX&search=search
DTCC: http://search2.dtcc.com/?q=Novavax%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Novavax%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Novavax%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.novavax.com
Alexa: http://www.alexa.com/siteinfo/http://www.novavax.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.novavax.com
Short Sales: http://www.otcmarkets.com/stock/NVAX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/NVAX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/NVAX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=NVAX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=NVAX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=NVAX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=NVAX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=NVAX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=NVAX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=NVAX
Balance Sheet: http://finance.yahoo.com/q/bs?s=NVAX
Cash Flow: http://finance.yahoo.com/q/cf?s=NVAX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/NVAX
Bloomberg: http://www.bloomberg.com/quote/NVAX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=NVAX
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVAX
Barchart: http://www.barchart.com/quotes/stocks/NVAX
OTC Short Report: http://otcshortreport.com/index.php?index=NVAX
Investopedia: http://www.investopedia.com/markets/stocks/NVAX/?wa=0
http://www.pennystocktweets.com/stocks/profile/NVAX
##### last known share structure ~ source: otcmarkets.com
Market Value: $1,048,471,006 a/o Jul 03, 2014
Shares Outstanding: 209,275,650 a/o Apr 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/NVAX
fi2110
Recent NVAX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:07:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 12:05:26 PM
- Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News • IH Market News • 05/10/2024 12:02:56 PM
- Novavax Reports First Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 05/10/2024 06:15:00 AM
- Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines • PR Newswire (US) • 05/10/2024 06:00:00 AM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/08/2024 08:53:29 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 09:21:35 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/07/2024 06:43:55 PM
- Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024 • PR Newswire (US) • 05/07/2024 01:25:00 PM
- Tesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More News • IH Market News • 05/07/2024 11:44:00 AM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 08:43:09 PM
- Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting • GlobeNewswire Inc. • 05/06/2024 10:22:33 AM
- Shah Capital nominates two highly qualified independent director candidates for Novavax • GlobeNewswire Inc. • 04/15/2024 10:00:00 AM
- Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:14 AM
- Novavax to Participate in TD Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/29/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:07:50 PM
- Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights • PR Newswire (US) • 02/28/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 12:30:55 PM
- Goldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and More • IH Market News • 02/23/2024 01:03:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 11:02:36 AM
- Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement • PR Newswire (US) • 02/22/2024 11:00:00 AM
- Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024 • PR Newswire (US) • 02/20/2024 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 01:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:00:09 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM